financetom
Market
financetom
/
Market
/
Kivah Advisors says domestic investors continue to remain cautious; see value in beaten down midcaps
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Kivah Advisors says domestic investors continue to remain cautious; see value in beaten down midcaps
Nov 27, 2020 7:45 AM

Mithun Aswath, managing partner of Kivah Advisors on Friday said he believes that domestic investors continue to remain cautious. However, there is value in some of the beaten down midcap stocks.

He said, "The midcap space has still not reached all-time highs. You have seen the Nifty reach its all-time high, while the mid and small caps have still lagged behind. That is primarily also because we have not seen similar amount of flows into the mid and small cap fund area."

Aswath said he has invested in pharmaceuticals, technology, and some auto names. However, currently he likes the travel and retail space.

"Within the retail space one of the stocks that we have advised to clients recently is a company called Raymond which trades at a huge discount to its asset value at the current levels. As things have started to open up, maybe in this Diwali quarter, you will see revenue move back up for a company like Raymond," he said.

On Cera Sanitaryware, Aswath said, "The company is a leader in the sanitaryware, faucets, as well as tiles space. It is mainly in the former 2 categories and addresses tier-2 and tier-3 markets which have been less impacted by COVID. The last quarter was hit because of their own issues they had in their factories. But in the second half, we do think there could be a big recovery."

Disclaimer: The views and investment tips expressed by investment experts on CNBCTV18.com are their own and not that of the website or its management. CNBCTV18.com advises users to check with certified experts before taking any investment decisions.

Watch the video for more

(Edited by : Jomy Pullokaran)

First Published:Nov 27, 2020 4:45 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
NASDAQ Cannabis Titan, Aurora, Could Boost 31% Sales Surge With This New CBD Lozenge Partnership
NASDAQ Cannabis Titan, Aurora, Could Boost 31% Sales Surge With This New CBD Lozenge Partnership
Aug 26, 2024
Aurora Cannabis Inc. ( ACB ) has partnered with Vectura Fertin Pharma, Inc. to launch a CBD lozenge in the form of a dissolvable tablet that delivers the precise dose of cannabidiol (CBD). The new product is expected to enhance patient care by providing an alternative consumption method without psychoactive effects. The partnership leverages Aurora’s extensive medical cannabis patient platform,...
TherapeuticsMD And 2 Other Stocks Under $2 Executives Are Buying
TherapeuticsMD And 2 Other Stocks Under $2 Executives Are Buying
Aug 26, 2024
The Dow Jones index closed higher by more than 450 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company’s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insider transactions for...
Sector Update: Financial
Sector Update: Financial
Aug 26, 2024
08:57 AM EDT, 08/26/2024 (MT Newswires) -- Financial stocks were advancing premarket Monday, with The Financial Select Sector SPDR Fund (XLF) 0.3% higher. The Direxion Daily Financial Bull 3X Shares (FAS) was 1% higher and its bearish counterpart Direxion Daily Financial Bear 3X Shares (FAZ) was down 1.2%. Prestige Wealth ( PWM ) shares were up past 118% after the...
Sector Update: Health Care
Sector Update: Health Care
Aug 26, 2024
08:55 AM EDT, 08/26/2024 (MT Newswires) -- Health care stocks were steady pre-bell Monday as the Health Care Select Sector SPDR Fund (XLV) and iShares Biotechnology ETF (IBB) were inactive recently. BeiGene ( BGNE ) shares were up more than 2% after saying BGB-16673 received fast track designation from the US Food and Drug Administration for potentially treating relapsed or...
Copyright 2023-2025 - www.financetom.com All Rights Reserved